Back

Risk stratification guided by NT-proBNP after cardiac rehabilitation in patients with ST-segment elevation myocardial infarction.

29 August 2025 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Biomarkers in acute coronary syndromes (2) Postinfarction Period ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Hector Manuel Merenciano Gonzalez

Instituto de Investigacion Sanitaria INCLIVA, Valencia (Spain)

7 More presentations in this session

Presentation thumbnail
Clonal Hematopoiesis of Indeterminate Potential (CHIP) mutations in patients with coronary artery disease
Doctor N. Senguttuvan (Chennai, IN)
Abstract Slides Video
Presentation thumbnail
Albumin-based inflammation scores with integrated thrombotic markers outperform conventional predictors for mortality in acute coronary syndrome and atrial fibrillation
Doctor H. Liang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
The clinical significance of misleading troponin elevations: is macrotroponin a culprit for unnecessary invasive coronary angiography?
Mr A. Holst Kronborg (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Novel admission hyperglycaemia markers as predictors of poor outcomes following percutaneous coronary interventions: a dose-response meta-analysis
Mr P. Siahaan (Surabaya, ID)
Abstract Slides Video
Presentation thumbnail
Diagnostic and prognostic utility of neutrophil-to-lymphocyte ratio as a biomarker in patients with acute chest pain
Mr B. Okamura (Basel, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Biomarkers in acute coronary syndromes (2)

The Event

Event poster

ESC Congress 2025

29 August 2025 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic implications of N-terminal pro-brain natriuretic peptide in patients with Non-ST segment elevation myocardial infarction
thumbnail
Congress Presentation
Utility of NT-proBNP for detecting heart failure and assessing prognosis in elderly myocardial infarction survivors: insights from the OMEMI trial
thumbnail
Congress Presentation
N-terminal prohormone of brain natriuretic peptide predicts recurrent cardiovascular events in patients with acute coronary syndrome both in the acute and post-discharge setting: a TRACER substudy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources